Articles
Plain explanations of what these assessments measure, written for the person having them and for the clinician reading the report.
-
HPA Axis Dysfunction in Chronic Pain: What to Measure Beyond Cortisol
Cortisol values in chronic pain point in both directions and one large cohort found no prediction at all. Which exposures justify screening, and which metabolic and autonomic measures to document.
-
Sleep Deprivation and Insulin Resistance: Who to Screen in Pain Care
Restricted and mistimed sleep lower clamp-measured insulin sensitivity within days. How that changes screening, measurement and documentation for chronic pain patients with disrupted sleep.
-
Carpal Tunnel and Diabetes: Hand Diagnoses as Screening Triggers
Entrapment neuropathy, trigger finger and adhesive capsulitis as dysglycemia screening triggers: the causal genetics, why A1c does not grade tissue, and pre-procedure planning.
-
Frozen Shoulder and Diabetes: The Numbers Worth Checking
A frozen shoulder can be an early blood sugar finding. How glycation stiffens collagen, why a single A1c misses it, and which measurements to ask about.
-
NSAID Cardiovascular Risk in Chronic Pain: Who to Measure and Why
Trial data quantify NSAID vascular and renal risk; practice rarely measures it. Who to select, why CRP is a poor gatekeeper, what a finding changes, and how to build the screen.
-
Screening for Hyperinsulinemia in Patients With Neuropathic Pain
Hyperinsulinemia runs for years behind normal glucose and tracks small-fiber and endothelial injury. Who to screen, how to read insulin assays, what changes.